The role of Matrix Gla Protein gene variants (G-7 A and T-138 C) in susceptibility to ischemic stroke: a case-control study
摘要
Matrix Gla Protein (MGP) plays a critical role in vascular calcification and extracellular matrix regulation, processes implicated in cerebrovascular pathology. This study aimed to evaluate the potential association between two MGP gene single nucleotide polymorphisms (SNPs), G-7 A (rs1800801) and T-138 C (rs1800802), and susceptibility to ischemic stroke.
Methods and ResultsA total of 230 individuals, including 115 patients with ischemic stroke and 115 healthy controls, were enrolled. Genomic DNA was extracted, and genotyping was performed using the PCR-RFLP method. Genotype and allele frequencies were statistically compared to assess their association with disease risk. No significant association was observed between the G-7 A polymorphism and ischemic stroke under genotype distribution or genetic models (p = 0.33; allelic model OR: 0.77, 95% CI: 0.52–1.14). In contrast, the T-138 C variant demonstrated statistically significant differences between groups (p = 0.015) and was associated with increased ischemic stroke risk under dominant (OR: 1.89, 95% CI: 1.12–3.19), recessive (OR: 3.54, 95% CI: 1.13–11.12), and allelic models (OR: 1.83, 95% CI: 1.20–2.78), suggesting a possible relationship with stroke susceptibility.
ConclusionsThese findings indicate that the MGP T-138 C polymorphism may contribute to ischemic stroke risk and could serve as a potential biomarker, whereas the G-7 A variant appears to be unrelated to disease susceptibility. Further large-scale studies are needed to confirm these results. This is the first study to evaluate this association in a Turkish population.